Buscar
Mostrando ítems 31-36 de 36
Predictors of in-hospital mortality in HIV-infected patients with COVID-19
(QJM: An International Journal of Medicine, 2023)
Background Underlying immunodeficiency is associated with severe COVID-19, but the prognosis of persons with human immunodeficiency virus (HIV) (PWH) with COVID-19 is under debate. Aim: assessment of the mortality rate and ...
Prospects for Controlling Hepatitis B Globally
(Pathogens, 2024)
Infection with the hepatitis B virus (HBV) is highly prevalent globally. Over 250 million people suffer from chronic hepatitis B, and more than 800,000 patients die each year due to hepatitis B complications, including ...
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
(AIDS Review, 2023)
Viruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. ...
COVID-19 mortality amongst the immunosuppresed
(Journal of Infection, 2024)
[Resumen no disponible]
Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients
(GigaByte, 2024)
Despite the advances in genetic marker identification associated with severe COVID-19, the full genetic characterisation of the disease remains elusive. This study explores imputation in low-coverage whole genome sequencing ...
Hospitalisations With Cryoglobulin‐Related Diseases in Spain Over 25 Years
(Liver International, 2025)
Background: The epidemiology of cryoglobulinemia in Spain has likely changed following the widespread adoption of direct-acting antivirals (DAAs) since 2015 for the treatment of hepatitis C virus (HCV) infection, the ...
